BUZZ-China's AIM Vaccine slumps on discounted share sale

Reuters02-28

** Shares of AIM Vaccine Co 6660.HK drop 12.5% to HK$5.48, on course for biggest one-day pct decline since October 9, 2024

** Vaccine developer and manufacturer says it will sell 15.5 mln new shares to third-party investors, raising HK$77.7 million ($9.99 million) for R&D of pre-clinical and clinical programs, new products development, and for working capital

** Says shares will be issued at HK$5.01 apiece, a 19.97% discount to Thursday's close of HK$6.26

** Hang Seng Commerce & Industry Index .HSNC drops 2.3%, healthcare index .HSCIH falls 2.1% and Hang Seng Index .HSI eases 1.9%

($1 = 7.7777 Hong Kong dollars)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment